Step-by-step Pharmaceutical: the proposed provision for impairment of goodwill is 2.94 billion yuan.

FAP, June 13 / PRNewswire-FirstCall-Asianet /-- step Pharmaceutical announced that it adjusted the amount of goodwill impairment provision for 2022 affected by the correction of previous accounting errors. Tonghua Valley Red is related to goodwill impairment provision of 868 million yuan, Jilin Tiancheng is related to goodwill impairment provision of 2.075 billion yuan. The provision for impairment of goodwill is 2.943 billion yuan, and the impairment loss will reduce the company's total profit by 2.943 billion yuan.